What Are Wall Street Analysts’ Forecasts for Exelon?
Will Exelon Beat 3Q15 Earnings Estimates?
Wall Street’s estimates for Exelon
In part one of this series, we have noted that Exelon’s (EXC) stock has fallen since January 21, 2015. Exelon’s stock has underperformed the Utilities Select Sector SPDR Fund (XLU) during the same time period. In this article, we will see what some brokerages have recommended for Exelon.
Consensus ratings for Exelon
Approximately 45.5% of the analysts tracking Exelon have rated it a “strong buy” or some equivalent. Approximately 9% rate the company a “buy” or an equivalent while approximately 45.5% recommended a “hold.” The average broker target price for Exelon is ~$36.4.
Analyst recommendations for Exelon
J.P. Morgan (JPM) has reiterated an “overweight” rating for Exelon with a target price of $39 per share. Exelon traded at $30.18 on October 23, 2015, indicating a ~30% return over the next 12 months. Evercore, part of Evercore Partners (EVR), has increased the target price of Exelon from $36 per share to $37 per share. This indicates a ~23% return over the next 12 months.
RBC Capital Markets, part of Royal Bank of Canada (RBC), has reiterated an “outperform” rating on Exelon, but cut the target price from $39 per share to $35 per share. This indicates a ~16% return over the next 12 months.
Macquarie, a leading global investment banking and diversified financial services group, has reiterated an “outperform” rating on Exelon with a target price of $40 per share. This indicates a ~33% return over the next 12 months.
SunTrust Robison Humphrey (STI), Guggenheim, and Bernstein have given Exelon a target price of $34 per share. This indicates a ~13% return over the next 12 months.
Browse this series on Market Realist:
